A 39-year-old male without any significant complaints or symptoms presented with a calcified lesion located at the sellar region. Total removal of the lesion has been achieved via an endoscopic endonasal transsphenoidal approach. Histopathological examination of the lesion revealed a pituitary stone.
InTROdUcTIOn
According to radiological series, up to 14% of pituitary adenomas may show calcifications, whereas this incidence may rise up to 25% in histological series (7, 20) . However, large calcified intrasellar mass, defined as pituitary stone, is a distinct and rare type of calcareous deposits within a pituitary adenoma. So far, eighteen cases including the present case have been reported in the English literature (2, 3, 5, 7, 11, 13-16, 18, 20, 23, 25) .
In this report, we present a unique case of a pituitary stone that originated from a plurihormonal pituitary adenoma showing immunreactivity for prolactin (PRL), thyroid stimulating hormone (TSH), and growth hormone (GH). Also, it differs from previously reported cases in terms of management of the lesion: this is the first pituitary stone case operated via fully endoscopic endonasal transsphenoidal route. Additionally, we provide a review of previous cases to discuss important clinical aspects and possible pathophysiological mechanisms behind this clinical phenomenon.
cASe RePORT
Thirty-nine year old male presented with chronic nonlocalizing headache. The patient had no remarkable medical and family history. At the time of admission, physical examination did not reveal any sign of neurological deficit or morphological changes. Magnetic resonance imaging (MRI) revealed a heterogenic sellar mass that was slightly hyperintense with sparse hypointense nodularity in the lesion on both T1-and T2-weighted images and was enhancing heterogeneously after gadolinium administration. The lesion was 15,6x15.2x13.7 mm in size and was showing minimal suprasellar extension but no invasion of the cavernous sinuses ( Figure 1A -E). Computed tomography (CT) scan showed prominent calcifications at the periphery and center of the lesion (Figure 2A-D) . Hormone studies revealed nothing abnormal except a slight decrease in IGF-1 level (Table I) . Hence, the patient underwent removal of the lesion, which was preliminary diagnosed as a craniopharyngioma, via endoscopic endonasal transsphenoidal route. Intraoperatively, the lesion, which was gray-yellow in color and had stone-like consistency, was totally removed with the help of suction and 
dIScUSSIOn
We present a case of pituitary stone within a mix-type pituitary adenoma with multiple hormone secretion, consisting of PRL, TSH, and GH. To our knowledge, this is the first case of a mixed hormone secreting pituitary adenoma harboring a pituitary stone that was removed via fully endoscopic endonasal transsphenoidal route. (Table II) (2, 20) . This lead us to that excessive PRL secretion may not be the main mechanism for type 1 pituitary stones. On the other hand, numerous reports have proposed pituitary apoplexy as the possible cause of pituitary stones (7, 8, 23) . Degenerative changes, which have been reported to be common in pituitary apoplexy, may lead to massive calcifications within the pituitary adenoma (8) . Additionally, although pituitary apoplexy may present with alarming signs and symptoms, silent apoplexy with no or minimal symptoms has also been described and may be chronic enough to compose a pituitary stone (7).
Until now, only eighteen cases have been reported in the English literature (Table II) . In sixteen of 18 cases, including our case, these deposits are formed only by calcifications (2, 3, 5, 7, 11, (14) (15) (16) 20, 23, 25) . However, on rare occasions, ossification of the adenoma can be present (13, 18) . Therefore, we found it useful to classify pituitary stones into two groups by their histological findings: Type 1, pituitary stones formed by prominent calcification and Type 2, pituitary stones formed by osteoid metaplasia.
Pathophysiological mechanisms behind both types remain yet to be understood. Hormones secreted by the adenoma and factors involved in the vascularization of the tumor have been proposed to play important role (2,17). Rilliet et al. stated about 75% of calcified pituitary adenomas are prolactinomas (21) . Additional reports also suggested that prolactinomas are more likely to form calcifications and proposed that increased levels of PRL may be the cause of The mechanism for type 2 pituitary stones is also unclear. Six cases of pituitary adenomas with ossification have been described before (9, 13, 18, 19, 22, 26) . However, only two of these cases, which both were PRL-secreting adenomas, showed extensive ossification and therefore were in concordance with the diagnosis of a pituitary stone due to their sizes (13, 18) . Another four cases, 2 with GH-secreting adenomas (19, 22) and 2 with gonadotropin-secreting adenomas (9, 26) , had calcareous deposits mostly in egg-shell form; therefore, they were not considered as pituitary stones.
Various reports have proposed several possible causes of ossification. The animal study of Clement-Lacroix et al.
showed PRL has an effect on osteoblasts and so on normal bone formation (4). However, based on diversity of hormones secreted in six cases, Jaiswal et al. have recently concluded that the mechanism behind osteoid metaplasia may not be related to only one hormone (9) . In an earlier case report, Mukada et al. suggested that intratumoral bleeding and tumor cell degeneration due to previous gonadotropin treatment might have provoked the ossification (18). Zahariadis et al.
held insufficient blood supply of the large tumor in their case responsible for ossification (26) . Thus, it seems, similar to as in type 1 pituitary stones, hypersecretion of PRL may not be the main cause of osteoid metaplasia, but due to the effects of PRL on osteoblast, we may assume that PRL has a role in excessive ossification and consequently the formation of a pituitary stone as it is in two cases of PRL-secreting adenomas.
Differential diagnosis of calcified lesions in the sellar region includes pituitary adenomas, meningiomas, craniopharyngiomas, and more uncommonly chordomas, chondrosarcomas, teratomas, and aneurysms (1, 13, 26) . Meningiomas are the second most common lesions in the sellar region just after pituitary adenomas and are more likely to calcify than pituitary adenomas, but they may have a dural tail and are mostly suprasellar lesions rather than pure sellar (6, 10, 24) . Therefore, meningioma was excluded since our case was pure intrasellar with no sign of dural tail. Since calcification is more commonly seen in craniopharyngiomas, of which 45-57% show calcifications, our preliminary diagnosis was a craniopharyngioma (12) . However, in the light of ultimate diagnosis of the presented case, pituitary stones should also be taken into consideration in differential diagnosis of calcifying tumors in the sellar region.
Carapella et al. stated hormone secretion may continue despite total calcification of the pituitary adenoma (2). Therefore, total removal of pituitary stones should be the goal of the treatment. We believe that neuroendoscopy provides an excellent intraoperative view and promotes easy handling and removal of these tumors.
cOnclUSIOn
To our knowledge, this is the first case report of a pituitary stone originating from a mixed-hormone secreting pituitary adenoma. Moreover, for the first time, a pituitary stone has been removed via endoscopic endonasal transsphenoidal route. Additionally, we proposed a classification of pituitary stones based on review of the previously published cases to have a better understanding of the pathophysiological mechanisms behind this clinical phenomenon. 
